Endometrial glandular hyperplasia
Conditions
Interventions
Group A:Remazolam besylate combined with afentanil, initial dose of afentanil 0.5mg(5ml), fractional addition of afentanil 0.25mg(2.5ml), not more than 1mg(10ml).
Group S:Remazolam besylate combined with Sufentanil, initial dose of sufentanil 5µg(5ml), sufentanil 2.5µg(2.5ml), not more than 10µg(10 mL).
Group F:Remazolam besylate combined with fentanyl, initial dose of fentanyl 0.05mg(5ml), fractional addition of fentanyl 0.025mg(2.5ml), not more than 0.1mg(10ml).
Group B:Remazolam besylate combined with butorphanol, initial dose of butorphanol 0.5mg(5ml), plus butorphanol 0.25mg in batches, not more than 1mg(10ml).
Sponsors
Dongyang Women and Children's Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: American Society of Anesthesiologists (ASA) Grade I to II; Age 18 ~ 60 years old; BMI 18 ~ 28?/m2, patients with hysteroscopic surgery.
Exclusion criteria
Exclusion criteria: ? History of mental illness; History of asthma; History of neurological disorders; People who are allergic to multiple foods or drugs; People with known allergies to benzodiazepines and opioids; ? Anemia: hemoglobin =90g/L; ? History of chronic pain; A long history of opioid use; Drug addicts and alcoholics; ? Patients with severe heart disease; Patients with severe hypertension and arrhythmia; Preoperative systolic blood pressure > 180mmHg and/or diastolic blood pressure > 110mmHg; ? Abnormal physiological states such as lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of anesthesia during operation;Recovery time;Incidence of adverse reactions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure;Heart rate;Blood oxygen saturation;MOAA/S score;satisfaction;VAS score;SCI score; | — |
Countries
China
Contacts
Public ContactYingchun Shi
Dongyang Women and Children's Hospital
Outcome results
None listed